Comment by DennisP

I'm not against regulation in principle. In this case, full disclosure of exactly what's in the drug should definitely be required. People's doctors can make informed decisions after that.

Restricting this to patients who are otherwise out of options is probably also a good idea. Pancreatic cancer would certainly qualify.